Search Results (2)

A novel electrochemical DNA sensor was developed for the detection of the anthracycline drug, valrubicin, on the base of poly(Azure C) electropolymerized from the deep eutectic solvent reline and covered with adsorbed DNA from calf thymus. Biosensor assembling was performed by multiple scanning of the potential in one drop (100 µL) of the dye dissolved in reline and placed on the surface of a screen-printed carbon electrode. Stabilization of the coating was achieved by its polarization in the phosphate buffer. The electrochemical characteristics of the electron transfer were determined and compared with a similar coating obtained from phosphate buffer. The use of deep eutectic solvent made it possible to increase the monomer concentration and avoid using organic solvents on the stage of electrode modification. After the contact of the DNA sensor with valrubicin, two signals related to the intrinsic redox activity of the coating and the drug redox conversion were found on voltammogram. Their synchronous changes with the analyte concentration increased the reliability of the detection. In the square-wave mode, the DNA sensor made it possible to determine from 3 µM to 1 mM (limit of detection, 1 µM) in optimal conditions. The DNA sensor was successfully tested in the voltammetric determination of valrubicin in spiked artificial urine, Ringer-Locke solution mimicking plasma electrolytes and biological samples (urine and saliva) with a recovery of 90–110%. After further testing on clinical samples, it can find application in the pharmacokinetics studies and screening of new drugs’ interaction with DNA. Full article

New highly sensitive voltammetric DNA-sensors have been developed for the detection of cytostatic drug doxorubicin based on Azure A electropolymerized on various carbon nanomaterials, i.e., functionalized multi-walled carbon nanotubes (fMWCNTs) and carbon black (CB). Carbon materials promote electropolymerization of the Azure A dye applied as a matrix for DNA molecules saturated with methylene blue (MB) molecules. Interaction with the intercalator (doxorubicin) liberates the MB molecules and changes redox activity. The doxorubicin concentration ranges reached by cyclic voltammetry were from 0.1 pM to 100 nM (limit of detection, LOD, 0.03 pM) for the biosensor based on CB, and from 0.3 pM to 0.1 nM (LOD 0.3 pM) for that based on fMWCNTs. DNA-sensors were tested on spiked samples of artificial serum, and biological and pharmaceutical samples. The DNA-sensors can find further application in the monitoring of the doxorubicin residuals in cancer treatment, as well as for pharmacokinetics studies. Full article